SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-001696
Filing Date
2018-02-09
Accepted
2018-02-08 20:58:29
Documents
53
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 755038
2 ex31-1.htm EX-31.1 15319
3 ex32-1.htm EX-32.1 7310
  Complete submission text file 0001493152-18-001696.txt   5746038

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ppcb-20171231.xml EX-101.INS 783800
5 XBRL SCHEMA FILE ppcb-20171231.xsd EX-101.SCH 59091
6 XBRL CALCULATION FILE ppcb-20171231_cal.xml EX-101.CAL 51567
7 XBRL DEFINITION FILE ppcb-20171231_def.xml EX-101.DEF 235184
8 XBRL LABEL FILE ppcb-20171231_lab.xml EX-101.LAB 385711
9 XBRL PRESENTATION FILE ppcb-20171231_pre.xml EX-101.PRE 290268
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 18587406
SIC: 2834 Pharmaceutical Preparations